Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C

Reona Morio,Michio Imamura,Yoshiiku Kawakami,Kei Morio,Tomoki Kobayashi,Satoe Yokoyama,Yuki Kimura,Yuko Nagaoki,Tomokazu Kawaoka,Masataka Tsuge,Akira Hiramatsu,C. Nelson Hayes,Hiroshi Aikata,Shoichi Takahashi,Daiki Miki,Hidenori Ochi,Nami Mori,Shintaro Takaki,Keiji Tsuji,Kazuaki Chayama

Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C

2017

Background Daclatasvir and asunaprevir combination therapy has shown a high virological response for chronic genotype 1 hepatitis C virus (HCV)-infected patients. However, the safety and efficacy of the therapy for older patients are unknown.

Keywords:

Hepatitis C virus
Hepatitis C
Daclatasvir
Combination therapy
Asunaprevir
Medicine
Physical therapy
Hepatology
General surgery
Hepacivirus
Young adult
Internal medicine
Gastroenterology
Viral load

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations